Drugs / hypertonic saline/dextran
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00316004 | May 2006 → May 2009 | traumatic brain injury | University of Washington | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hypertonic saline/dextran | “A single 250-mL bolus of 7.5% saline/6% dextran 70 (hypertonic saline/dextran), 7.5% saline (hypertonic saline), or 0.9% saline (normal saline) initiated in the out-of-hospital setting.” PMID 20924011 ↗ Oct 2010 |
| Known as | HSD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00316004 ↗ |
| Route | Intravenous | “250 ml intravenous bolus administration of 7.5% saline/6% dextran 70 administered as a one-time bolus fluid for initial resuscitation” NCT00316004 ↗ |